Thermogenesis Holdings Analysis
THMODelisted Stock | USD 0.32 0.01 3.03% |
Thermogenesis Holdings is overvalued with Real Value of 0.3 and Hype Value of 0.32. The main objective of Thermogenesis Holdings delisted stock analysis is to determine its intrinsic value, which is an estimate of what Thermogenesis Holdings is worth, separate from its market price. There are two main types of Thermogenesis Holdings' stock analysis: fundamental analysis and technical analysis.
The Thermogenesis Holdings stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Thermogenesis Holdings is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Thermogenesis Stock trading window is adjusted to America/New York timezone.
Thermogenesis |
Thermogenesis Stock Analysis Notes
About 56.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.56. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Thermogenesis Holdings recorded a loss per share of 3.98. The entity last dividend was issued on the 5th of June 2019. The firm had 1:45 split on the 22nd of December 2022. ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor and other cell-based therapies. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California. Thermogenesis Holdings operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs people. To find out more about Thermogenesis Holdings contact Xiaochun MBA at 916 858 5100 or learn more at https://www.thermogenesis.com.Thermogenesis Holdings Investment Alerts
Thermogenesis Holdings is not yet fully synchronised with the market data | |
Thermogenesis Holdings has some characteristics of a very speculative penny stock | |
Thermogenesis Holdings has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 9.45 M. Net Loss for the year was (18.92 M) with profit before overhead, payroll, taxes, and interest of 3.49 M. | |
Thermogenesis Holdings currently holds about 3.9 M in cash with (3.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09. | |
Roughly 56.0% of the company outstanding shares are owned by corporate insiders |
Thermogenesis Holdings Upcoming and Recent Events
Earnings reports are used by Thermogenesis Holdings to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
4th of April 2024 Upcoming Quarterly Report | View | |
20th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
4th of April 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Thermogenesis Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.47 M.Thermogenesis Profitablity
The company has Profit Margin (PM) of (1.53) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.2) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.2.Thermogenesis Holdings Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Thermogenesis Holdings insiders, such as employees or executives, is commonly permitted as long as it does not rely on Thermogenesis Holdings' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Thermogenesis Holdings insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Haihong Zhu over six months ago Disposition of 5000 shares by Haihong Zhu of Thermogenesis Holdings at 30.0 subject to Rule 16b-3 | ||
Xu Xiaochun over six months ago Disposition of tradable shares by Xu Xiaochun of Thermogenesis Holdings at 0.38 subject to Rule 16b-3 | ||
Xu Xiaochun over a year ago Sale by Xu Xiaochun of 600000 shares of Thermogenesis Holdings | ||
Xu Xiaochun over a year ago Conversion by Xu Xiaochun of 654206 shares of Thermogenesis Holdings | ||
Stracey Robin C over a year ago Acquisition by Stracey Robin C of 15000 shares of Thermogenesis Holdings subject to Rule 16b-3 | ||
Xu Xiaochun over a year ago Conversion by Xu Xiaochun of tradable shares of Thermogenesis Holdings |
Thermogenesis Holdings Outstanding Bonds
Thermogenesis Holdings issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Thermogenesis Holdings uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Thermogenesis bonds can be classified according to their maturity, which is the date when Thermogenesis Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MPLX LP 4875 Corp BondUS55336VAG59 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
International Game Technology Corp BondUS460599AD57 | View |
Thermogenesis Holdings Predictive Daily Indicators
Thermogenesis Holdings intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Thermogenesis Holdings stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Thermogenesis Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Thermogenesis Holdings prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Thermogenesis shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Thermogenesis Holdings. By using and applying Thermogenesis Stock analysis, traders can create a robust methodology for identifying Thermogenesis entry and exit points for their positions.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor and other cell-based therapies. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California. Thermogenesis Holdings operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Thermogenesis Holdings to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
All Next | Launch Module |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Thermogenesis Stock
If you are still planning to invest in Thermogenesis Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thermogenesis Holdings' history and understand the potential risks before investing.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |